Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.28 $5.69 Thursday, 9th May 2024 MBRX stock ended at $4.78. This is 1.70% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 9.54% from a day low at $4.61 to a day high of $5.05.
90 days $0.400 $6.23
52 weeks $0.338 $6.23

Historical Moleculin Biotech Inc prices

Date Open High Low Close Volume
Apr 04, 2024 $5.29 $5.31 $5.10 $5.30 14 128
Apr 03, 2024 $5.33 $5.63 $5.09 $5.25 46 552
Apr 02, 2024 $5.70 $5.70 $5.18 $5.45 28 597
Apr 01, 2024 $5.79 $6.05 $5.67 $5.67 27 023
Mar 28, 2024 $5.63 $6.23 $5.18 $5.91 77 480
Mar 27, 2024 $4.80 $5.69 $4.75 $5.54 88 464
Mar 26, 2024 $4.95 $4.99 $4.34 $4.68 90 400
Mar 25, 2024 $6.00 $6.00 $4.65 $5.25 908 975
Mar 22, 2024 $5.56 $6.22 $5.32 $5.70 97 141
Mar 21, 2024 $0.407 $0.489 $0.407 $0.442 660 506
Mar 20, 2024 $0.520 $0.520 $0.400 $0.421 953 959
Mar 19, 2024 $0.540 $0.590 $0.524 $0.524 42 073
Mar 18, 2024 $0.550 $0.570 $0.550 $0.550 105 858
Mar 15, 2024 $0.552 $0.560 $0.480 $0.495 101 633
Mar 14, 2024 $0.580 $0.580 $0.490 $0.536 193 662
Mar 13, 2024 $0.560 $0.580 $0.560 $0.560 39 670
Mar 12, 2024 $0.631 $0.631 $0.560 $0.561 192 520
Mar 11, 2024 $0.689 $0.690 $0.626 $0.632 41 674
Mar 08, 2024 $0.688 $0.690 $0.660 $0.674 74 167
Mar 07, 2024 $0.670 $0.677 $0.634 $0.670 83 351
Mar 06, 2024 $0.680 $0.680 $0.660 $0.670 77 947
Mar 05, 2024 $0.660 $0.688 $0.660 $0.674 117 531
Mar 04, 2024 $0.630 $0.690 $0.601 $0.688 269 541
Mar 01, 2024 $0.630 $0.650 $0.600 $0.611 125 024
Feb 29, 2024 $0.608 $0.633 $0.595 $0.629 56 953
Click to get the best stock tips daily for free!

About Moleculin Biotech Inc

Moleculin Biotech Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial fo... MBRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT